Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistance.

Cancer chemotherapy and pharmacology - 1 Jan 2005

Samimi Goli, Manorek Gerald, Castel Rob, Breaux James K, Cheng Tim C, Berry Charles C, Los Gerrit, Howell Stephen B

Abstract excerpt

In order to identify genes whose expression is associated with resistance to the chemotherapeutic agent oxaliplatin, transcripts differentially expressed between an oxaliplatin sensitive and a stably resistant subline were compared in six independent replicates using Stanford cDNA microarrays for five cell lines. "Significance analysis of microarrays" (SAM) was used to identify genes whose expression was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine Triphosphate
Share to Carcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Squamous Cell

Share to Head and Neck Neoplasms

Share to Organoplatinum Compounds

Share to Ovarian Neoplasms

Share to Oxaliplatin

Share to Up-Regulation

Source

Identifiers

PMID: 15378272
DOI: 10.1007/s00280-004-0819-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistance.PMID 15378272Read ↗

Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancerSemantic proximity Read ↗

TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approachSemantic proximity Read ↗

A highly annotated database of genes associated with platinum resistance in cancerSemantic proximity Read ↗

In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancerSemantic proximity Read ↗

Functional Genomics Reveals Diverse Cellular Processes That Modulate Tumor Cell Response to OxaliplatinSemantic proximity Read ↗

Identification of Novel miRNAs, Targeting Genes, Signaling Pathway, and the Small Molecule for Overcoming Oxaliplatin Resistance of Metastatic Colorectal CancerSemantic proximity Read ↗

Construction and Validation of an Oxaliplatin-Resistant Gene Signature in Colorectal Cancer Patients Who Underwent ChemotherapySemantic proximity Read ↗

GABRP is a potential chemoresistance regulator in colorectal cancerSemantic proximity Read ↗

Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780/C10Semantic proximity Read ↗

The cellular pharmacology of oxaliplatin resistanceSemantic proximity Read ↗

Mechanistic and predictive profiling of 5-Fluorouracil resistance in human cancer cells.Semantic proximity Read ↗

Oxaliplatin induces different cellular and molecular chemoresistance patterns in colorectal cancer cell lines of identical origins.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.